Hexciter
Experienced member
- Messages
- 2,575
- Reactions
- Nation of residence
-
- Nation of origin
-
French science advisory board made a statement that it is not possible before 2023 to completely return to normal.
COVID-19
- Thread starter Test7
- Start date
Hexciter
Experienced member
- Messages
- 2,575
- Reactions
- Nation of residence
-
- Nation of origin
-
A new type of mutation has emerged in the UK which is different from all previous.
Ryder
Experienced member
- Messages
- 10,857
- Reactions
- Nation of residence
-
- Nation of origin
-
- Messages
- 4,754
- Reactions
- Nation of residence
-
- Nation of origin
-
I am pro vaccine.
My father and mother got Vaccinated 3 times.
Yet I didn’t get once, because I was too lazy to go and take it.
Ryder
Experienced member
- Messages
- 10,857
- Reactions
- Nation of residence
-
- Nation of origin
-
I am pro vaccine.
My father and mother got Vaccinated 3 times.
Yet I didn’t get once, because I was too lazy to go and take it.
My dad never got it either. We booked him an appointment and he ran away.
It was reported that the Kovid-19 test of Jill Biden, wife of US President Joe Biden, was "positive", while Biden's test was "negative".
www.aa.com.tr
ABD Başkanı Biden'ın eşinin Kovid-19 testi "pozitif" çıktı
ABD Başkanı Joe Biden'ın eşi Jill Biden'ın Kovid-19 testinin "pozitif" çıktığı, Biden'ın testinin ise "negatif" olduğu bildirildi. - Anadolu Ajansı
www.aa.com.tr
My source told me that many people are still dying in China, #COVID never left. Another friend in the #US told me that many of her friends and colleagues got infected after traveling to #China recently. Some of them coughed terribly. They only gradually recovered after returning to the US. She felt this very strange. Photo: A man holds an urn containing the ashes of a loved one at a #crematorium in Beijing on December 20, 2022. Staff at the crematorium in Beijing say they are overwhelmed.
Four senior #CCP generals died in just four days.
They are: Zhang Liqiong (张力雄), Founding Major General of the People's Republic of China Han De Cai (韩德彩) ,
Lieutenant General of CPC and former Deputy Commander of the Air Force of the Nanjing Military Region Huo Ling(霍玲),
Rear Admiral of the CPC Navy, and the former Chief Engineer of a Naval Base Song Wenhan (宋文汉),
Lieutenant General of the CPC, former Deputy Commander of the Guangzhou Military Region, and retired cadre with the rank of Deputy Grand Military Region.
The "death list" I started to compile a while ago keeps growing. (I stopped doing it for a while as I was too busy.) Anyway, the red colored ones are the newly added ones since I posted my last list.
@Kartal1 @Test7 @Zafer @Ryder @Gary @Rodeo @Yasar_TR @TR_123456 @Fuzuli NL @OPTIMUS @Afif
Last edited:
Zafer
Experienced member
- Messages
- 4,683
- Reactions
- Nation of residence
-
- Nation of origin
-
My source told me that many people are still dying in China, #COVID never left. Another friend in the #US told me that many of her friends and colleagues got infected after traveling to #China recently. Some of them coughed terribly. They only gradually recovered after returning to the US. She felt this very strange. Photo: A man holds an urn containing the ashes of a loved one at a #crematorium in Beijing on December 20, 2022. Staff at the crematorium in Beijing say they are overwhelmed.
Four senior #CCP generals died in just four days.
They are: Zhang Liqiong (张力雄), Founding Major General of the People's Republic of China Han De Cai (韩德彩) ,
Lieutenant General of CPC and former Deputy Commander of the Air Force of the Nanjing Military Region Huo Ling(霍玲),
Rear Admiral of the CPC Navy, and the former Chief Engineer of a Naval Base Song Wenhan (宋文汉),
Lieutenant General of the CPC, former Deputy Commander of the Guangzhou Military Region, and retired cadre with the rank of Deputy Grand Military Region.
The "death list" I started to compile a while ago keeps growing. (I stopped doing it for a while as I was too busy.) Anyway, the red colored ones are the newly added ones since I posted my last list.
@Kartal1 @Test7 @Zafer @Ryder @Gary @Rodeo @Yasar_TR @TR_123456 @Fuzuli NL @OPTIMUS
This reminded me of a dream I had seen about Covid-19. Before that, I was one of the very first people who caught the disease in Türkiye as when I started coughing nobody had heard the word Covid-19 in the World. I caught it from a neighbor of mine who traveled from Singapore to Istanbul. Seeing him after several decades I had given him a welcoming hug and I paid for it dearly. I hadn't coughed in decades before and because it was by the end of the year it wasn't before I started to recover that I saw a doctor, anyway.
The dream I had I shared in a few media but was not shared further. In the dream it was a setting in history like before the age of fire arms. A city was invaded by a Chinese army. People were captured and put in earth colored sacks and there were several dozen people in sacks on the street, I woke up when I was to be captured and made a move to get free. Anyway, people were put in sacks and were given a ration of food for one day, after the food is gone they would die. A hell of a nightmare.
China has a big population and the disease can survive longer as there are distant please where healthcare maybe insufficient therefore the disease bounces back. I was told in a telephone conversation today that a variant of Covid-19 is in circulation here too and a relative of mine was down possibly with it and we cancelled an iftar dinner because of it.
I fear global warming can thaw frozen microbes to start another plague or a bio-weapon can do the same.
Be safe.
Last edited:
A retired colonel friend of mine who is a microbiologist just said that we expect a shutdown in Turkey in May.
Zafer
Experienced member
- Messages
- 4,683
- Reactions
- Nation of residence
-
- Nation of origin
-
I assume he didn't give more detail you can share.
Unfourtunatily
COVID-19 Linked to ‘Alarming Rise’ of Rare and Highly Lethal Fungal Infection
SARS-CoV-2 and the overuse of certain treatments may be contributing to a surge in secondary mucormycosis infections when underlying health conditions exist.The COVID-19 pandemic has caused an alarming rise of an aggressive and highly fatal secondary fungal infection among those with active or recovered COVID-19.
Research suggests that the SARS-CoV-2 virus, the overuse of immunosuppressive COVID-19 treatments such as corticosteroids and antibiotics, and the global pandemic response made people more susceptible to coinfections such as COVID-19-associated mucormycosis (CAM).
Mucormycosis, also known as black fungus, is an opportunistic fungal infection that typically affects the sinuses, lungs, and brain. It is caused by a group of molds commonly found in the environment. Before COVID-19, these fungi rarely caused infection because of low virulence, but the second wave of COVID-19 brought tens of thousands of reported cases. Even the Omicron variant, which was generally attributed to mild COVID-19, has been linked to lethal mucormycosis infections in the United States and Asia.
According to the Centers for Disease Control and Prevention, there are several types of mucormycosis:
- Rhinocerebral mucormycosis is an infection of the sinuses that can spread to the brain and is most commonly diagnosed in people with diabetes or in those who have had a kidney transplant.
- Pulmonary mucormycosis is the most common type of mucormycosis, mainly affecting people with cancer or those who have had organ or stem cell transplants.
- Gastrointestinal mucormycosis affects the digestive tract and is more common among children and young adults.
- Cutaneous mucormycosis is the most common form of infection among those without weakened immune systems. It occurs when the fungi enter through a cut, scrape, or surgical incision in the skin.
- Disseminated mucormycosis is where the infection gets into the bloodstream and spreads to the brain and other organs. The mortality rate with this type of mucormycosis is 96 percent.
The symptoms of mucormycosis vary depending on the patient, their underlying medical conditions, and the organs affected by the infection. Early symptoms may include nasal pain, vision loss, headache, fever, blackish nasal discharge, facial pain on one side, and mouth swelling. The infection primarily affects the nose, sinuses, lungs, eyes, and brain but can disseminate through the blood to other areas of the body.
According to a 2023 paper published in Travel Medicine and Infectious Disease, mucormycosis strikes patients within 12 to 18 days after COVID-19 recovery, and nearly 80 percent require surgery. A delayed or untreated diagnosis can result in a mortality rate as high as 94 percent.
COVID-19-Associated Mucormycosis Is a ‘Worldwide Phenomena’
In a 2022 review published in The Lancet, researchers analyzed 80 cases of COVID-19-associated mucormycosis from 18 countries, including eight cases from the United States, and found mucormycosis infection can be a serious complication of severe COVID-19, especially for those with diabetes and hyperglycemia, or high blood sugar.Additionally, the authors noted that systemic corticosteroid treatment can reduce mortality in people with severe COVID-19, but the treatment, combined with immunological and other clinical factors, can also predispose patients to secondary fungal diseases like mucormycosis. This particular infection is associated with high morbidity and mortality, even in those with mild COVID-19 cases. The same is true for COVID-19 patients who received intensive antibiotic treatment.
Of the 80 cases analyzed by researchers, 74 patients were hospitalized for COVID-19 after receiving a mucormycosis diagnosis. In six cases, patients had COVID-19 before hospitalization for mucormycosis-associated symptoms—four of whom were hospitalized for COVID-19 within one to three months before a mucormycosis diagnosis.
Researchers identified 59 patients with rhino-orbital cerebral disease, 20 with pulmonary disease, and one had gastrointestinal mucormycosis. With cerebral mucormycosis, the fungus initially invades the nasal cavity and paranasal sinuses, presenting similarly to acute sinusitis. It can then lead to angioinvasion, where tumor cells get through blood vessel walls and cause blood clots. The infection rapidly spreads to orbital and brain sites and is associated with high morbidity and mortality.
Nearly 50 percent (39 patients) died. The median survival time from the day of the mucormycosis diagnosis was 106 days for rhino-orbital cerebral disease and only nine days for patients with pulmonary mucormycosis. Among survivors, 46 percent (19 patients) lost their vision.
The researchers noted several underlying health conditions among the patients with mucormycosis in addition to COVID-19, including uncontrolled or poorly controlled diabetes, hypertension or high blood pressure, chronic kidney disease, and cancer. Those with diabetes were more likely to have rhino-orbital mucormycosis and mild to moderate cases of COVID-19. Those without diabetes were more likely to have other manifestations of the infection and severe COVID-19. Researchers found that pulmonary mucormycosis almost exclusively occurred in the ICU setting.
The Lancet paper’s corresponding author, Dr. Martin Hoenigl, is an associate professor of translational mycology at the Division of Infectious Diseases at the Medical University of Graz, Austria, and the current president of the European Confederation of Medical Mycology.
“Our study outlines that COVID-19-associated mucormycosis, although more prevalent in parts of the world that have traditionally higher mucormycosis rates due to higher levels of environmental exposure (e.g., India, Pakistan, Iran, Egypt, China), is a worldwide phenomenon,” Dr. Hoenigl told The Epoch Times in an email.
“Our study has been performed early during the COVID pandemic before the extent of the COVID-19 associated mucormycosis crisis in India was recognized/came into the public focus, and raises attention to this serious, often deadly complication that can be very difficult to diagnose and requires aggressive treatment for a chance of successful outcome,” he said.
Numerous countries observed a sudden increase in CAM cases in 2021 during the second wave of the pandemic. India, a “hot spot” for the deadly infection, typically diagnosed 50 cases of mucormycosis each year but had already observed 28,252 cases as of June 2021. The number of mucormycosis cases has been increasing since.
Deadly Fungal Infection More Common With COVID-19
Dr. Hoenigl told The Epoch Times that mucormycosis is more common with COVID-19 than other infectious diseases due to specific risk factors that emerged with the pandemic and its management, as well as specific immunological mechanisms that predispose patients with severe COVID-19 to developing the condition.“In terms of clinical risk factors, the increased population of undiagnosed or uncontrolled diabetes (driven by reduction of routine healthcare services during the early COVID pandemic) was an important driver of COVID-19 associated mucormycosis, as was overuse of systemic corticosteroids for COVID-19 treatment that happened in some countries where steroids were available for purchase over the counter, and at the same time, there was a lack of availability of supplemental oxygen,” Dr. Hoenigl said.
“In terms of immunological mechanisms, conditions such as hyperglycemia, steroid overuse, and high levels of iron and ketone bodies, but also COVID-19 itself via the virus-induced endoplasmic reticulum stress cascade are upregulating the expression of glucose-regulated protein 78 (GRP78), which, besides acting as a cofactor in viral entry, binds to spore-coating CotH3 invasin on the fungal surface and favors invasion of nasal epithelial cells by mucorales, resulting in rhino-orbital cerebral mucormycosis,” he explained.
The endoplasmic reticulum (ER) is a large structure within a cell that performs many functions, including calcium storage, protein synthesis, and lipid metabolism. GRP78 plays a significant role in regulating the ER. It is often upregulated in patients with COVID-19, which predisposes people to getting mucormycosis.
GRP78 helps regulate the ER’s stress response, can form a complex with the spike protein and the angiotensin-converting enzyme 2 (ACE2) to encourage entry and infection of SARS-CoV-2, and acts as a host receptor that allows molds that cause mucormycosis to enter cells and cause disease.
“There are other important immunological mechanisms as well that explain how severe COVID-19 can predispose patients to develop mucormycosis,” Dr. Hoenigl added.
Other Studies Identify Mucormycosis Risk Factors
In a 2021 review published in the Journal of Infection and Public Health, researchers found that hyperglycemia, impaired immunity, acidosis, raised ferritin—which is often indicative of higher iron levels, inflammation, or infection—glucocorticoid therapy, and COVID-19-specific factors were implicated in the pathogenesis of CAM.In a 2022 study published in Cureus, researchers followed 62 patients with cerebral mucormycosis for up to 12 weeks to evaluate the risk factors, symptoms, and impact of various interventions on the disease outcome. All participants reported being symptomatic with flu-like illness during the two months preceding their diagnosis, with 58 of the 62 subjects testing positive for COVID-19 and 54 of the 58 patients receiving treatment.
“COVID-19 patients are more susceptible to opportunistic fungal infections due to the immune dysregulation caused by iatrogenic immunosuppression (via corticosteroids or undefined antibiotic treatment), uncontrolled diabetes mellitus, use of invasive or noninvasive ventilation, and other pre-existing conditions,” the paper’s authors wrote.
The researchers found that COVID-19 and diabetes mellitus were significant risk factors for developing mucormycosis. Common signs and symptoms of mucormycosis often appeared within a few weeks of COVID-19, although neurological symptoms were either absent or appeared later. The most common initial symptoms included ptosis—a drooping eyelid—or severe headache.
The median time between COVID-19 infection and the first noticeable symptom of mucormycosis was 16 days. The mean time between the first symptom of mucormycosis and the first neurological symptom was 19 days. The most common initial neurological symptom was hemiparesis—a weakness or inability to move one side of the body.
The study found that 18 (29 percent) patients were symptomatic for mucormycosis even before the resolution of their COVID-19. At the end of 12 weeks, only 18 patients had completely recovered without any residual symptoms, while 19 had persistent symptoms.
Of the 62 subjects, 53 required surgical intervention, eight patients needed their eyes extracted, 21 patients died, 37 survived, and four were lost at follow-up. The higher-than-expected survival rate was attributed to the study occurring in a hospital facility with access to prompt antifungal treatments.
In a January review of 20 papers on mucormycosis and COVID-19, researchers discovered numerous fungal coinfections in COVID-19 patients, 0.3 percent of which were related to mucormycosis.
The researchers attributed CAM to hyperglycemia from previously existing diabetes or excessive use of steroids, increased ferritin levels due to the “inflammatory cascade” initiated by COVID-19, immunological and inflammatory phenomena that occur with SARS-CoV-2 infection, immunosuppression from steroid use or other therapies, germination of fungal spores due to reduced white cell counts in those with COVID-19, and hypoxia—or insufficient oxygen levels which promote growth of the fungus.
Researchers also found that fungal infections were greater in critically ill COVID-19 patients, those requiring mechanical ventilation, and those hospitalized for more than 50 days.
According to the paper, medical management of the disease includes antifungal treatments and surgical debridement of the associated lesions. This is challenging for COVID-19 patients because many are given immunosuppressive therapies, such as steroids, and withdrawing immunosuppressive medications used to treat COVID-19 is part of the treatment for mucormycosis. They further suggest using hyperbaric oxygen therapy for hypoxia and acidosis.
To prevent mucormycosis in those with COVID-19, researchers suggest taking a detailed medical history to assess risk factors, using a controlled steroid regimen, sterilizing water in humidifiers, halting excessive antibiotics, and controlling blood sugar.
COVID-19 Linked to ‘Alarming Rise’ of Rare and Highly Lethal Fungal Infection
SARS-CoV-2 and the overuse of certain treatments may be contributing to a surge in secondary mucormycosis infections when underlying health conditions exist.
@Rodeo @Anmdt @Ryder @UkroTurk @TR_123456 @Fuzuli NL @Zafer @Mis_TR_Like @Yasar_TR @Nilgiri @Sanchez @Kartal1 @MADDOG
